Randomized trial shows intermittent fasting lowers HbA1c in adults with Type 1 diabetes — Evidence Review
Published in Diabetes Care, by researchers from UIC
Researched by
— the AI search engine for science
Table of Contents
A new randomized trial suggests that adults with type 1 diabetes and obesity who limit their eating to an eight-hour window each day may achieve lower blood sugar without increased safety risks; this aligns with findings from previous studies in type 1 and type 2 diabetes showing that intermittent fasting can be safe and beneficial when properly supervised. Most related research supports the safety and modest efficacy of intermittent fasting or time-restricted eating for glycemic control in diabetes, though the evidence for type 1 diabetes has been limited until now, and larger studies are still needed to confirm these results from the original source.
- Related studies indicate that intermittent fasting can be performed safely in people with type 1 diabetes when healthcare providers monitor glucose levels and medication adjustments are made as needed 1 3 4.
- Both intermittent fasting and caloric restriction have demonstrated improvements in glycemic parameters and body composition in diabetes, but their relative efficacy compared to each other and to standard care varies depending on study design and population 2 5 13.
- While most prior work has focused on type 2 diabetes, evidence from pilot studies and clinical reviews suggests that structured fasting regimens may also be feasible and beneficial for people with type 1 diabetes under proper medical supervision 1 3 4.
Study Overview and Key Findings
Research into dietary strategies for managing diabetes has traditionally centered on type 2 diabetes, with limited data on type 1 diabetes, particularly in adults who also have obesity. This new study addresses an important gap by assessing the safety and effectiveness of a time-restricted eating (TRE) regimen—eating only between noon and 8 p.m., without calorie counting—compared to calorie restriction and standard care. The study is notable for being the first randomized controlled trial to investigate TRE in adults with type 1 diabetes and obesity and for its focus on clinically meaningful outcomes such as HbA1c and adverse diabetes events.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | UIC |
| Journal Name | Diabetes Care |
| Authors | Mary-Claire Runchey, Sarah Corapi, Vasiliki Pavlou, Sofia Cienfuegos, Shuhao Lin, Mark Ezpeleta, Kelsey Gabel, Lisa Tussing-Humphreys, Vanessa M. Oddo, Shaina J. Alexandria, Julienne Sanchez, Terry Unterman, Lisa S. Chow, Alaina P. Vidmar, Sirimon Reutrakul, Krista A. Varady |
| Population | Adults with Type 1 diabetes and obesity |
| Sample Size | 32 participants |
| Methods | Randomized Controlled Trial (RCT) |
| Outcome | Blood sugar levels, HbA1c results |
| Results | Time-restricted eating group had 0.5% lower HbA1c than calorie group. |
Literature Review: Related Studies
To contextualize this study, we searched the Consensus database of over 200 million research papers using the following queries:
- intermittent fasting type 1 diabetes
- time-restricted eating HbA1c levels
- caloric restriction blood sugar comparison
Below is a summary table of major themes and key findings from related studies:
| Topic | Key Findings |
|---|---|
| Can intermittent fasting and time-restricted eating be safe for type 1 diabetes? | - Intermittent fasting can be safe for people with type 1 diabetes when supervised and with appropriate glucose monitoring 1 3 4. - Structured education and advanced glucose monitoring support safe fasting in type 1 diabetes, reducing acute complications 3 4. |
| How effective is intermittent fasting or time-restricted eating for glycemic control in diabetes? | - Fasting and time-restricted eating can modestly improve HbA1c, glycemic variability, and fat metabolism in type 1 and type 2 diabetes 2 5 6 7 8. - Time-restricted eating has shown benefits for blood sugar and weight loss in type 2 diabetes, but effects are not always superior to calorie restriction 5 6 7 13. |
| What are the risks and limitations of intermittent fasting for diabetics? | - Constant monitoring is necessary to prevent hypoglycemia, especially in insulin-treated patients 1 5. - Most clinical studies are small, short-term, and lack long-term safety data, especially in type 1 diabetes 1 5 4. |
| How does caloric restriction compare to intermittent fasting for metabolic outcomes? | - Both approaches improve glycemic control and body composition, but intermittent fasting is not consistently superior to calorie restriction for most outcomes 13 14 15. - Caloric restriction remains a well-supported intervention for improving cardiometabolic risk factors 12 14 15. |
Can intermittent fasting and time-restricted eating be safe for type 1 diabetes?
Several studies indicate that with proper supervision and glucose monitoring, people with type 1 diabetes can safely undertake intermittent fasting. This includes both religious fasting (e.g., Ramadan) and structured interventions. The new study's findings are consistent with this evidence, demonstrating no increased risk of severe hypoglycemia or diabetic ketoacidosis over six months of time-restricted eating.
- Clinical reviews and pilot studies emphasize the need for healthcare provider supervision and personalized glucose monitoring for safety 1 3.
- Structured education and use of continuous glucose monitoring systems further reduce the risk of acute complications such as hypoglycemia and ketoacidosis 3 4.
- A 7-day fasting intervention in adults with type 1 diabetes was feasible and safe, with only temporary and manageable side effects 4.
- Patient selection is important: those with stable, uncomplicated type 1 diabetes are best suited for fasting interventions 3.
How effective is intermittent fasting or time-restricted eating for glycemic control in diabetes?
The literature shows that intermittent fasting and time-restricted eating can modestly improve glycemic control, including reductions in HbA1c and glycemic variability, in both type 1 and type 2 diabetes. However, the degree of benefit can vary, and effects are often similar to those achieved with calorie restriction.
- Fasting regimens have been shown to lower HbA1c, improve fat metabolism, and increase insulin sensitivity in type 1 and type 2 diabetes, especially when supervised 2 5 6 7 8.
- Time-restricted eating without calorie counting has been found effective for weight loss and lowering HbA1c in adults with type 2 diabetes, with effects comparable to daily calorie restriction 7.
- Some studies found no significant differences in glycemic control between intermittent fasting and control diets, highlighting the importance of adherence and individual response 5 10.
- Benefits in body composition, such as reductions in total and visceral fat, have also been observed in overweight/obese populations practicing time-restricted eating 9.
What are the risks and limitations of intermittent fasting for diabetics?
Despite promising results, intermittent fasting in diabetes requires careful monitoring due to the risk of hypoglycemia, especially for those on insulin therapy. Most studies have been of limited duration and small sample size, leaving questions about long-term safety and efficacy.
- Clinical management guidelines stress the need for personalized monitoring and adjustments to insulin regimens to minimize hypoglycemia 1 5.
- No severe hypoglycemic events were reported in structured studies, but constant vigilance is required 3 5.
- Many published studies in this area are small, short-term, or pilot investigations, limiting generalizability 1 5 4.
- Larger, multicenter trials with longer follow-up are needed, particularly in type 1 diabetes 1 5.
How does caloric restriction compare to intermittent fasting for metabolic outcomes?
Meta-analyses and randomized trials suggest that both caloric restriction and intermittent fasting improve glycemic control, body weight, and cardiovascular risk factors. However, intermittent fasting does not consistently outperform caloric restriction, and both approaches may be effective depending on patient preference and adherence.
- Intermittent fasting and caloric restriction both reduce body weight, waist circumference, and fat mass, with intermittent fasting showing no clear superiority over caloric restriction for most outcomes 13 14 15.
- Caloric restriction alone is a well-supported intervention for improving cardiometabolic risk factors and achieving diabetes remission in type 2 diabetes 12 14 15.
- The choice between dietary interventions should consider individual lifestyle, preferences, and ability to adhere to the regimen long-term 13 15.
- More research is needed in type 1 diabetes to clarify whether intermittent fasting offers unique advantages over calorie restriction 2 13.
Future Research Questions
The current evidence supports the short-term safety and modest efficacy of time-restricted eating in adults with type 1 diabetes and obesity, but many questions remain. Larger studies with longer follow-up are needed to evaluate the durability of glycemic improvements, the impact on diabetes complications, and the optimal implementation of fasting interventions in diverse populations. The following questions highlight key areas for future investigation:
| Research Question | Relevance |
|---|---|
| What are the long-term effects of time-restricted eating in adults with type 1 diabetes? | Long-term safety and efficacy data are lacking, especially regarding complications, sustainability, and quality of life in type 1 diabetes 1 4 5. |
| Does time-restricted eating reduce the risk of diabetes-related complications in type 1 diabetes? | It is unknown if improved glycemic control from TRE translates to lower rates of retinopathy, nephropathy, or cardiovascular events 2 4. |
| How does time-restricted eating compare to calorie restriction for glycemic control in type 1 diabetes? | Direct comparisons are limited, but both approaches appear beneficial; more head-to-head trials are needed to determine which is more effective or sustainable 13 14. |
| What is the role of continuous glucose monitoring in supporting safe fasting practices in type 1 diabetes? | Continuous glucose monitoring has been shown to enhance safety during fasting, but best practices for implementation and patient education require further study 3 4. |
| Are there specific subgroups of type 1 diabetes patients who benefit most from time-restricted eating? | Factors such as age, duration of diabetes, obesity, and comorbidities may influence response to TRE, but have not been systematically studied 2 4. |